El Servidor brand ground cinnamon recalled because of elevated levels of lead

recalled ground cinnamon

Gutierrez Distributor of Passaic, NJ, is recalling El Servidor Corp brand ground cinnamon because it has the potential to be contaminated with elevated levels of lead. 

El Servidor Corp ground cinnamon was distributed to retail stores in New York starting on Jan. 14, 2024.

The product comes in a 1.5-ounce clear plastic bag. The recall was the result of a sample analysis conducted by New York State Department of Agriculture and Markets (NYSAGM) that revealed the product contained elevated levels of lead. The company has ceased the production and distribution of the product as FDA and the company continues their investigation as to what caused the problem.

Consumers should discontinue use of the product immediately and are urged to return it to the place of purchase for a full refund. Consumers with questions may contact the company at 973-777-1851.

Short term exposures to very low levels of lead may not elicit any symptoms. It is possible that increased blood lead levels may be the only apparent sign of lead exposure. Additional signs and symptoms of lead exposure are more likely with acute exposure to higher levels of lead or chronic exposure to lead. 

While lead can affect nearly every bodily system, its effects depend upon the amount and duration of lead exposure and age/ body weight. If a child is exposed to enough lead for a protracted period of time (e.g., weeks to months) permanent damage to the central nervous system may occur. This can result in learning disorders, developmental defects, and other long-term health problems. For adults, chronic lead exposure is associated with kidney dysfunction, hypertension, and neurocognitive effects. 

No illnesses have been reported to date in connection with this problem.

(To sign up for a free subscription to Food Safety News,click here)

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Rituximab and COVID Shots: Studies Begin to Answer Key Questions thumbnail

Rituximab and COVID Shots: Studies Begin to Answer Key Questions

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Rituximab has presented something of a conundrum for patients taking the monoclonal antibody during the COVID-19 pandemic. Used to manage a variety of autoimmune diseases and cancers, rituximab acts against CD20 proteins expressed on the surface of B cells, causing B-cell…
Read More
The New(ish) Fight Over Fluoride thumbnail

The New(ish) Fight Over Fluoride

IF YOU’D LIVED in Grand Rapids, Michigan, in 1945, you’d have been one of the first people in America to sip fluoridated tap water. As of 2024, about 73 percent of us get the mineral in our water supply. And for almost 80 years, there’s been nonstop drama around that addition. In 1956, Clive McCay
Read More
Index Of News
Total
0
Share